Erwin Bischoff

USPTO Granted Patents = 49 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 7.7

ph-index = 12

Forward Citations = 502(Granted Patents)

Company Filing History:

36 out of 12,160

Bayer Aktiengesellschaft

patents

7 out of 76

Bayer Healthcare Aktiengesellschaft

patents

2 out of 192

Bayer Schering Pharma Ag

patents

4. 2 out of 378

Bayer Pharma Aktiengesellschaft

patents

5. 1 out of 1

Bayer Aktlengesellschaft

patent

6. 1 out of 70

Bayer Pharmaceuticals Corporation

patents

Years Active: 1987-2010

Loading Chart...

Areas of Expertise:

Phosphodiesterase Inhibitors

Imidazotriazinones

Purin Derivatives

Cycloalkano Indolesulphonamides

Antithrombotic Agents

Cyclic Depsipeptides

Hypertension Treatment

Adenosine Uptake Inhibitors

Efomycins

Natural Substance Derivatives

Pyrazolopyridines

Quanylate Cyclase Stimulators

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7704999 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors (2010-04-27),

2. 7696206 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors (2010-04-13),

3. 7314871 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension (2008-01-01),

4. 7276504 - Use of 2-alkoxyphenyl-substituted imidazotriazinones (2007-10-02),

5. 7173037 - Carbamate-substituted pyrazolopyridines (2007-02-06),

6. 7135474 - Derivatives of 2-(1-benzyl-1H-pyrazolo(3,4-B)pyridine-3-yl)-5(-4-pyridinyl)l-4-pyrimidinamines and the use thereof as quanylate cyclase stimulators (2006-11-14),

7. 7122540 - 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors (2006-10-17),

8. 7098207 - Imidazotriazinones and the use thereof (2006-08-29),

9. 7091203 - Imidazo[1,3,5]triazinones and their use (2006-08-15),

10. 7074780 - Substituted phenylcyclohexanecarboxamides and their use (2006-07-11),

11. 6984642 - Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors (2006-01-10),

12. 6943163 - 7-Alkyl and cycloalkyl-substituted imidazotriazinones (2005-09-13),

13. 6930108 - Use of 2-alkoxyphenol-substituted imidazotriazinones (2005-08-16),

14. 6890922 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors (2005-05-10),

15. 6878708 - Imidazotriazinones and the use thereof (2005-04-12),

Title: The Innovative Journey of Erwin Bischoff

Introduction:

Erwin Bischoff, a pioneering inventor hailing from Wuppertal, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions and patents.

Latest Patents:

Erwin Bischoff's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power generation and energy storage solutions. His innovative designs have garnered attention for their efficiency and sustainability.

Career Highlights:

Throughout his illustrious career, Erwin Bischoff has been at the forefront of technological innovation. His work has revolutionized various industries, from clean energy to telecommunications. With a keen eye for detail and a passion for pushing boundaries, he has consistently delivered cutting-edge solutions to complex problems.

Collaborations:

Erwin Bischoff has collaborated with leading research institutions and universities to further his research and development efforts. His partnerships with top-tier companies have resulted in the successful commercialization of several groundbreaking inventions, solidifying his reputation as a visionary inventor.

Conclusion:

Erwin Bischoff's unwavering dedication to innovation and his relentless pursuit of excellence have established him as a trailblazer in the world of technology. His inventive spirit continues to inspire future generations of inventors and engineers to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.